Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population
CompletedOBSERVATIONAL
Enrollment
150
Participants
Timeline
Start Date
September 1, 2024
Primary Completion Date
July 31, 2025
Study Completion Date
July 31, 2025
Conditions
Hyperlipidemias
Interventions
GENETIC
Atorvastatin
10mg once a day for 2 months
Trial Locations (1)
Unknown
Riphah International University, Rawalpindi
All Listed Sponsors
lead
Riphah International University
OTHER
NCT07148037 - Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population | Biotech Hunter | Biotech Hunter